ad image

Carna Biosciences

1 / 1
SeraNovo
License Agreement

SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor

SeraNovo

PR-M10-19-NI-046Oct 30, 2019
Evotec
Strategic Collaboration

Evotec and Carna Biosciences Collaborate on Indigo Platform

Evotec

PR-M05-18-NI-047May 11, 2018
1 / 1